Delivery Order SPE2DB20D1109-SPE2DB25FP14S
Award Date
5/29/25
Potential Completion Date
5/30/25
Potential Value
$3.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,860.82, is a delivery order for 4,568,150,902 tablets of the medication Levorphanol 2 mg. The contract has a completion date of May 7, 2025 and uses a firm fixed price pricing type. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp is a for-profit organization that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,019.52 firm fixed-price delivery order is for the supply of 4564437604 LEVORPHANOL 2 MG TABLET 100S, with a performance period through April 30, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,270.19 firm fixed-price delivery order is for LEVORPHANOL TABS 2MG, with a period of performance through March 25, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This federal contract award, with ID SPE2DX22D0010|SPE2D823FCT61, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $4,603.75 firm fixed-price delivery order is for the supply of Levorphanol Tablets 2mg, a pharmaceutical product. The contract has a completion date of January 11, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Levorphanol Tablets 2mg to the U.S. government. The contract, valued at $1,796.80, is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense. The contract has a firm fixed price and a completion date of June 20, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distribution company that holds a...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $3,927.24 to Amerisourcebergen Drug Corp's Corporate Office Division to provide 4,564,830,114 tablets of 2 mg Levorphanol, a prescription medication, by June 7, 2024. This contract is part of Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen supplies a comprehensive range...
This federal contract award is for the delivery of LEVORPHANOL 2 MG TABLET 100S to the Defense Logistics Agency (DLA). The award, valued at $1,918.22, was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price and has an ultimate completion date of August 13, 2024. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award, identified as SPE2DB20D1109 and SPE2DB25FN97A, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4,568,073,816 tablets of the pharmaceutical drug Levorphanol 2 mg, with a ceiling value of $3,969.02 and a performance period through April 30, 2025. The contract is a delivery order without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
This federal contract award, SPE2DX22D0010|SPE2D825FFP05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,293.98 firm fixed-price delivery order is for the supply of 4568199707 - Levorphanol Tabs 2mg, with a performance period extending to May 12, 2025. The contract is not set aside and is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract, valued at $35,926.50, is a delivery order with a firm fixed price pricing type and an ultimate completion date of April 22, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...